NHS England faces 9,490-patient cancer treatment shortfall

NHS England faces a 9,490-patient cumulative shortfall against its March 2027 cancer treatment target, The Guardian reported on Nov. 14, citing NHS figures and Radiotherapy UK calculations.

The immediate problem is scale: 70.7% of patients started treatment within 62 days in September, down from 71.9% in August and below the 80% interim target.

Radiotherapy UK calculated that NHS England would need to treat 24,400 cancer patients on time each month to reach the target in March, compared with about 21,500 now. That implies 2,850 additional on-time treatments a month, assuming patient volumes stay consistent.

Prof Pat Price, chair of Radiotherapy UK and an oncologist, said: “The government is going to miss its cancer treatment target because the NHS does not have enough staff or equipment to treat the number of patients coming through its doors. This lack of leadership means thousands more people could die because they don’t get their treatment on time.”

The 62-day measure covers patients who begin treatment after an urgent referral or consultant upgrade, when a case is escalated onto the cancer pathway. The target is an access standard, not an outcome measure, but delays can matter because cancer treatment is time-sensitive.

Performance varied sharply by cancer type in September. NHS figures and Radiotherapy UK’s analysis showed 60.9% of lung cancer patients, 60% of gynaecological cancer patients and 56.5% of head-and-neck cancer patients started treatment on time. Breast cancer was at 68.8%, and prostate cancer was at 70.1%.

Regional differences were also wide. London recorded 77.3% of cancer patients starting treatment within 62 days, compared with 66.6% in the Midlands, the lowest regional figure in the analysis.

Mark Lawler, professor of digital health and chair in translational cancer genomics at Queen’s University Belfast, attributed the missed progress to accountability and management failures. He said: “The whole system is being held together by goodwill glue alone. Lack of leadership is derailing efforts to improve cancer survival.

Unless there is accountability for these failures by the NHS, a radical change in mindset and a focus on the basics, we will miss hitting treatment targets for another decade.”

The treatment figures sit alongside weaker performance on cancer diagnosis. Cancer Research UK analysis cited by The Guardian showed 55.4% of patients with cancer were diagnosed within 28 days of an urgent referral over the past year, against an 80% faster diagnosis standard; 79.1% of patients who received the all-clear did so within the target.

Atlas360 reported on Nov. 6 that cancer registrations reached a record 373,000 in 2024 and that August figures remained below the 28-day diagnosis and 62-day treatment standards. The new September treatment rate shows the gap widened rather than narrowed.

The projections depend on patient volumes remaining consistent and do not establish how many deaths, if any, would result from missed treatment deadlines. The next benchmark is NHS England’s March 2027 target date for treating 80% of cancer patients within 62 days.

Source: news report, The Guardian Health, Nov. 14, 2026.

Atlas360 reports health research and does not provide medical advice.